Puma Biotechnology, Inc.
US ˙ NasdaqGS ˙ US74587V1070

SecurityPBYI / Puma Biotechnology, Inc.
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in PBYI / Puma Biotechnology, Inc.

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Puma Biotechnology, Inc. (US:PBYI) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 61,255 shares of Puma Biotechnology, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 0 -100.00 0
2025-11-13 2025-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 325 54.76 0.0004
2025-08-14 2025-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 210 16.02 0.0003
2025-08-14 2025-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 181 -3.21 0.0002
2025-05-15 2025-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 181 0.0002
2025-02-14 2024-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 187 19.87 0.0002
2024-11-14 2024-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 156 -22.00 0.0002
2024-08-09 2024-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 -1,529 -2.44 200 -38.46 0.0002
2024-05-14 2024-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 62,784 1,529 2.50 325 22.64 0.0004
2024-02-14 2023-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 265 64.60 0.0003
2023-11-14 2023-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 161 -25.46 0.0002
2023-10-27 2023-06-30 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 216 14.29 0.0002
2023-10-12 2023-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 216 0.0002
2023-08-14 2023-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 216 0.0002
2023-06-01 2023-03-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 189 -27.03 0.0002
2023-05-15 2023-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 189 0.0002
2023-02-21 2022-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 259 78.62 0.0003
2022-11-14 2022-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 145 -17.14 0.0002
2022-08-17 2022-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 175 -0.57 0.0002
2022-08-15 2022-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 175 0.0001
2022-05-16 2022-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 176 -5.38 0.0001
2022-02-11 2021-12-31 13F Puma Biotechnology COM 74587V107 61,255 -6,993 -10.25 186 -61.09 0.0002
2021-11-12 2021-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 68,248 6,354 10.27 478 -15.85 0.0004
2021-08-13 2021-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 61,894 0 0.00 568 -5.49 0.0005
2021-05-14 2021-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,894 -303 -0.49 601 -5.80 0.0008
2021-02-16 2020-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 62,197 0 0.00 638 1.59 0.0009
2020-11-13 2020-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 62,197 0 0.00 628 -3.24 0.0011
2020-08-11 2020-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 62,197 942 1.54 649 25.53 0.0011
2020-05-15 2020-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 0.00 517 -3.54 0.0011
2020-03-18 2019-12-31 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 61,255 -1,062,622 -94.55 536 -95.57 0.0008
2020-02-28 2019-12-31 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 61,255 0 536 0.0008
2020-02-14 2019-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 61,255 -1,062,622 536 672.6346
2019-11-14 2019-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 1,123,877 70,475 6.69 12,099 -9.63 0.0203
2019-11-06 2019-06-30 13F/A-2 PUMA BIOTECHNOLOGY COM 74587V107 1,053,402 66,234 6.71 13,389 -65.03 0.0226
2019-09-24 2019-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 1,053,402 0 13,389 0.0228
2019-08-14 2019-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 1,053,402 66,234 13,389
2019-05-15 2019-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 987,168 161,972 19.63 38,292 128.02 0.0653
2019-02-15 2018-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 825,196 176,733 27.25 16,793 -43.52 0.0324
2018-11-15 2018-09-30 13F PUMA BIOTECHNOLOGY COM 74587V107 648,463 175,699 37.16 29,732 6.32 0.0484
2019-03-21 2018-06-30 13F/A-1 PUMA BIOTECHNOLOGY COM 74587V107 472,764 472,764 27,964 0.0482
2018-08-14 2018-06-30 13F PUMA BIOTECHNOLOGY COM 74587V107 472,764 472,764 27,964
2018-05-11 2018-03-31 13F PUMA BIOTECHNOLOGY COM 74587V107 0 -300 -100.00 0 -100.00
2018-02-14 2017-12-31 13F PUMA BIOTECHNOLOGY COM 74587V107 300 300 30 0.0001
2016-05-16 2016-03-31 13F PUMA BIOTECHNOLOGY Common Stock 74587V107 0 0 0 0.0000
2016-02-16 2015-12-31 13F PUMA BIOTECHNOLOGY Common Stock 74587V107 0 -400 -100.00 0 -100.00
2015-11-16 2015-09-30 13F PUMA BIOTECHNOLOGY Common Stock 74587V107 400 0 0.00 30 -36.17 0.0001
2015-08-21 2015-06-30 13F/A-1 PUMA BIOTECHNOLOGY Common Stock 74587V107 400 -8,514 -95.51 47 -97.77 0.0001
2015-08-14 2015-06-30 13F PUMA BIOTECHNOLOGY Common Stock 74587V107 400 47
2015-05-18 2015-03-31 13F PUMA BIOTECHNOLOGY COMMON 74587V107 8,914 4,864 120.10 2,105 174.45 0.0041
2015-02-17 2014-12-31 13F PUMA BIOTECHNOLOGY COMMON 74587V107 4,050 4,050 767 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.